Purpose: The authors developed a Two Spots Enuretic Voiding Diary (TSEVD) that consisted of the first voiding amount (V1) after awakening and the single voiding amount (V2) for the patient's need to void before sleep. We evaluated the efficacy and usefulness of the TSFVD for the treatment of enuretic children. Materials and Methods: From Apr. 2002 to Feb. 2004, 71 patients with monosymptomatic nocturnal enuresis and 55 patients with polysymptomatic nocturnal enuresis were enrolled in this study. The treatment modality and termination were assigned by the V1, V2 and V3 (age-matched normal bladder capacity) on the TSEVD. Results: The percent of patients whose V3 exceeded their V2 and their ratios of V1/V2 and V2/V3 were decreased after treatment in both the monsymptomatic and polysymptomatic group. For the monosymptomatic patients, the submission rate, the good response rate and the cure rate were 73.7%, 19.7% and 65.6%, respectively, whereas the submission rate, the good response rate and cure rate for the polysymptomatic patients were 84.4%, 22.9% and 41.7%, respectively. The recurrence rates in both groups were 14.8% and 35.4%, respectively. Both the patients and parents showed good understanding of the TSEVD, the principles of treatment and their role in the treatment. The Student's t-test (paired) was used for the statistical analysis. Conclusions: These data suggests that the TSEVD was useful to evaluate the progress of treatment and the treatment goals for each patient suffering with nocturnal enuresis. The treatment end point, based on the TSEVD, was effective in reducing recurrence by determining the treatment effect.
- Treatment effectiveness
ASJC Scopus subject areas